To date, under controlled laboratory conditions, the tests have been more or less successful – we are talking about having close to 100% accuracy here. Just how is this made possible? Well, a fluorescent cross-responsive sensor array that features a special rotary gas chamber would be able to spread the gas evenly. There are dots located on the outside of the sensor ring that will change color, depending on the substance that they come in contact with.
By detecting the amount of fluorescence of the array because of the introduction of a gas, the device will then be able to spot the existence of specific biomarkers. So far, tests have shown the ability to spot cancer-related volatile organic compounds p-xylene, styrene, isoprene, and hexanal even at concentrations of up to 50 parts per billion. Clinical trials are the next logical step to take here.